OFIX

SEC source: 0000950170-25-033632 · ownership.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,124

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 14,401 previously reported restricted stock units.

SEC source: 0000950170-25-033627 · ownership.xml · derivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,731

Underlying: Common Stock · 8,731 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

SEC source: 0000950170-25-033627 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,817

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 32,565 previously reported restricted stock units.

SEC source: 0000950170-25-033620 · ownership.xml · derivative · entry 2

Vitale Lucas · CIK 0001763869 · CP&BO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,924

Underlying: Common Stock · 34,924 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

SEC source: 0000950170-25-033620 · ownership.xml · nonDerivative · entry 1

Vitale Lucas · CIK 0001763869 · CP&BO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,604

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 120,087 previously reported restricted stock units.

SEC source: 0000950170-25-033612 · ownership.xml · derivative · entry 2

Fisher Patrick · CIK 0001677842 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,924

Underlying: Common Stock · 34,924 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

SEC source: 0000950170-25-033612 · ownership.xml · nonDerivative · entry 1

Fisher Patrick · CIK 0001677842 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,042

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 15,319 previously reported restricted stock units.

SEC source: 0000950170-25-033606 · ownership.xml · derivative · entry 2

Cedron Jorge Andres · CIK 0002018980 · CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,908

Underlying: Common Stock · 41,908 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

SEC source: 0000950170-25-033606 · ownership.xml · nonDerivative · entry 1

Cedron Jorge Andres · CIK 0002018980 · CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,316

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 28,648 previously reported restricted stock units.

SEC source: 0000950170-25-033602 · ownership.xml · derivative · entry 2

Andrews Julie · CIK 0001550508 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,070

Underlying: Common Stock · 82,070 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

SEC source: 0000950170-25-033602 · ownership.xml · nonDerivative · entry 1

Andrews Julie · CIK 0001550508 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,912

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 21,979 previously reported restricted stock units.

SEC source: 0000950170-25-014490 · ownership.xml · nonDerivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,136

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 32,565 previously reported restricted stock units.

SEC source: 0000950170-25-014490 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,323

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 32,565 previously reported restricted stock units.

SEC source: 0000950170-25-007228 · ownership.xml · nonDerivative · entry 1

Andrews Julie · CIK 0001550508 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,312

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 21,979 previously reported restricted stock units.

SEC source: 0000950170-25-005369 · ownership.xml · nonDerivative · entry 2

Calafiore Massimo · CIK 0001828602 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,151

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive.

F3 · balance_after: Includes 94,057 previously reported restricted stock units.

SEC source: 0000950170-25-005366 · ownership.xml · nonDerivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,090

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive.

F3 · balance_after: Includes 35,639 previously reported restricted stock units.

SEC source: 0000950170-25-005369 · ownership.xml · nonDerivative · entry 1

Calafiore Massimo · CIK 0001828602 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,354

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

F3 · balance_after: Includes 94,057 previously reported restricted stock units.

SEC source: 0000950170-25-005366 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,317

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

F3 · balance_after: Includes 35,639 previously reported restricted stock units.

SEC source: 0000950170-25-004182 · ownership.xml · nonDerivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,565

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.74 to $17.115, inclusive.

F3 · balance_after: Includes 37,206 previously reported restricted stock units.

SEC source: 0000950170-25-004182 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,803

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.97 to $17.66, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

F3 · balance_after: Includes 37,206 previously reported restricted stock units.

SEC source: 0000950170-24-138470 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,041

F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

F2 · balance_after: Includes 38,758 previously reported restricted stock units.

SEC source: 0000950170-24-098561 · ownership.xml · derivative · entry 2

Fisher Patrick · CIK 0001677842 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,195

Underlying: Common Stock · 35,195 shares

Expires 2031-08-15

F2 · derivative.exercise_date: The options shall vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date on which the average closing price of the Company's common stock over a consecutive thirty (30) calendar day period has been equal to or greater than 150% of the option price or (ii) with respect to one-third (1/3rd) of the shares of Stock covered hereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares of Stock covered hereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0000950170-24-098561 · ownership.xml · nonDerivative · entry 1

Fisher Patrick · CIK 0001677842 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,319

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0000950170-24-075305 · ownership.xml · nonDerivative · entry 1

Kummeth Charles R. · CIK 0001534980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,502

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 23,502 deferred stock units.

SEC source: 0000950170-24-075304 · ownership.xml · nonDerivative · entry 1

Hannon Jason · CIK 0001330401 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,364

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 44,790 deferred stock units.

SEC source: 0000950170-24-075303 · ownership.xml · nonDerivative · entry 1

Paolucci Michael E · CIK 0001599463 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,766

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 54,700 deferred stock units.

SEC source: 0000950170-24-075302 · ownership.xml · nonDerivative · entry 1

Maniar Shweta · CIK 0001850826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,232

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 29,506 deferred stock units.

SEC source: 0000950170-24-075301 · ownership.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,914

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 29,506 deferred stock units.

SEC source: 0000950170-24-075299 · ownership.xml · nonDerivative · entry 1

Bazaar Alan Lee · CIK 0001296974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,088

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 24,088 deferred stock units.

SEC source: 0000950170-24-075298 · ownership.xml · nonDerivative · entry 1

Finegan Michael · CIK 0001391402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,718

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 29,718 deferred stock units.

SEC source: 0000950170-24-075297 · ownership.xml · nonDerivative · entry 1

BURRIS WAYNE · CIK 0001885420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,698

F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2 · balance_after: Includes 25,315 deferred stock units.

SEC source: 0000950170-24-072505 · ownership.xml · derivative · entry 2

REINHARDT MAX · CIK 0001780058 · President, Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,731

Underlying: Common Stock · 190,731 shares

Expires 2031-06-10

F2 · derivative.exercise_date: 33,103 of the stock options vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date certain service-based conditions are met (which will be met over three years) and (b) the date that the average closing price of the Company's common stock over a one-month calendar period has been equal to or great than 150% of the closing price of the Company's common stock on the grant date. The remaining 157,628 stock options vest on the third anniversary of the grant date.

SEC source: 0000950170-24-072505 · ownership.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Global Spine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,401

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0000950170-24-072487 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,747

F1 · balance_after: Includes 158,664 previously reported restriced stock units.

SEC source: 0000950170-24-045144 · ownership.xml · derivative · entry 2

Cedron Jorge Andres · CIK 0002018980 · CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,817

Underlying: Common Stock · 64,817 shares

Expires 2031-04-15

F2 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0000950170-24-045144 · ownership.xml · nonDerivative · entry 1

Cedron Jorge Andres · CIK 0002018980 · CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,648

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0000950170-24-044085 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,014

F1 · balance_after: Includes 146,435 previously reported restriced stock units.

SEC source: 0000950170-24-043032 · ownership.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,803

F1 · balance_after: Includes 32,763 previously reported deferred stock units.

SEC source: 0000950170-24-041302 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,952

F1 · balance_after: Includes 166,132 previously reported restricted stock units.

SEC source: 0000950170-24-041107 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,772

F1 · balance_after: Includes 38,859 previously reported restricted stock units.

SEC source: 0000950170-24-033563 · ownership.xml · derivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,381

Underlying: Common Stock · 8,381 shares

Expires 2031-03-15

F2 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0000950170-24-033563 · ownership.xml · nonDerivative · entry 1

Gillespie Geoffrey C · CIK 0001993483 · CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,842

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0000950170-24-011265 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,983

F1 · balance_after: Includes 171,297 previously reported unvested restricted stock units.

SEC source: 0000950170-24-029993 · ownership.xml · nonDerivative · entry 1

Bazaar Alan Lee · CIK 0001296974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,936

F1 · shares: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

SEC source: 0000950170-24-029983 · ownership.xml · nonDerivative · entry 1

Kummeth Charles R. · CIK 0001534980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,350

F1 · shares: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

SEC source: 0000950170-24-029988 · ownership.xml · nonDerivative · entry 1

Finegan Michael · CIK 0001391402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,350

F1 · shares: Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

SEC source: 0001209191-24-001811 · doc4.xml · derivative · entry 2

Andrews Julie · CIK 0001550508 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,878

Underlying: Common Stock · 76,878 shares

Expires 2031-01-15

F2 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-24-001811 · doc4.xml · nonDerivative · entry 1

Andrews Julie · CIK 0001550508 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,967

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0001209191-24-001272 · doc4.xml · derivative · entry 3

Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,967

Underlying: Common Stock · 10,967 shares

Expires 2031-01-08

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-24-001272 · doc4.xml · nonDerivative · entry 2

Gillespie Geoffrey C · CIK 0001993483 · VP, Controller, Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,385

F2 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F1 · balance_after: Includes 31,423 previously reported unvested restricted stock units.